IRWD
Ironwood Pharmaceuticals Inc
3.60$
-3.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 56.8% | 2.1% | 1.0% | 5.4% | 7.0% | 9.7% | 3.8% | 5.0% | 7.0% | 16.4% | 1.5% | 11.1% | 0.4% | 8.7% | 2.8% | 0.7% | 21.0% | 0.8% | 17.4% | 11.7% | 10.5% | 0.3% | 11.1% | 0.4% | 0.3% | 0.3% | 0.3% | 18.4% | 0.4% | 0.4% | 34.5% | 0.5% | 32.6% | 86.7% | 66.7% | 0.5% | 0.4% | 1.0% | 0.4% | – | – | |
| 43.2% | 97.9% | 99.0% | 94.6% | 93.0% | 90.3% | 96.2% | 95.0% | 93.0% | 83.6% | 98.5% | 88.9% | 99.6% | 91.3% | 97.2% | 99.3% | 79.0% | 99.2% | 82.6% | 88.3% | 89.5% | 99.7% | 88.9% | 99.6% | 99.7% | 99.7% | 99.7% | 81.6% | 99.6% | 100.0% | 65.5% | 100.0% | 67.4% | 100.0% | 33.3% | 99.5% | 99.6% | 100.0% | 99.6% | 100.0% | 99.8% | |
| 56.8% | 44.0% | 64.6% | 57.4% | 42.7% | 42.6% | 52.8% | 48.0% | 71.2% | 33.9% | 78.6% | 28.1% | 21.0% | 21.0% | 35.1% | 24.0% | 21.0% | 13.9% | 20.7% | 11.7% | 10.5% | 26.9% | 11.1% | 11.4% | 10.3% | 9.4% | 12.1% | 1,047.7% | 28.4% | 30.3% | 34.5% | 32.2% | 32.6% | 28.0% | 66.7% | 26.9% | 18.0% | 45.8% | 20.2% | 19.8% | 22.5% | |
| 68.1% | 63.1% | 106.6% | 88.8% | 71.1% | 61.5% | 89.5% | 84.3% | 84.1% | 44.5% | 94.2% | 42.3% | 31.2% | 31.0% | 45.6% | 38.7% | 33.8% | 29.1% | 31.1% | 26.0% | 26.7% | 24.5% | 29.6% | 31.0% | 26.3% | 26.5% | 29.9% | 48.9% | 31.7% | 32.9% | 50.2% | 39.2% | 39.4% | 37.1% | 59.0% | 19.7% | 17.9% | 40.4% | 11.3% | 10.0% | 16.6% | |
| 129.7% | 103.3% | 172.0% | 146.8% | 116.0% | 107.8% | 147.4% | 136.6% | 157.1% | 78.4% | 172.7% | 70.4% | 52.2% | 52.0% | 80.7% | 62.7% | 34.9% | 55.2% | 31.5% | 25.7% | 26.7% | 51.4% | 29.6% | 42.4% | 36.6% | 35.9% | 42.0% | 1,090.3% | 56.8% | 68.0% | 50.8% | 73.5% | 39.4% | 65.2% | 104.1% | 46.6% | 36.0% | 86.3% | 31.5% | 29.8% | 39.1% | |
| -42.8% | -7.2% | -76.1% | -63.0% | -22.4% | 24.2% | -51.9% | -49.2% | -257.4% | 4.6% | -79.1% | 21.1% | 50.2% | 39.3% | 16.5% | 36.6% | 44.1% | 44.0% | 51.1% | 62.6% | 62.8% | 48.3% | 59.3% | 57.2% | 63.0% | 63.8% | 57.8% | -1,008.7% | 42.7% | 32.0% | 14.7% | 26.5% | 28.0% | 34.8% | -70.7% | 52.9% | 63.6% | 13.7% | 68.1% | 70.2% | 60.6% | |
| 14.8% | 11.0% | 17.2% | 13.9% | 10.5% | 9.8% | 13.4% | 11.6% | 14.4% | 7.3% | 14.0% | 9.2% | 8.0% | 5.6% | 9.0% | 8.2% | 7.2% | 6.4% | 8.6% | 7.4% | 7.6% | 6.8% | 2.4% | 2.3% | 1.4% | 1.4% | 1.5% | 1.7% | 8.7% | 7.2% | 9.7% | 7.9% | 10.3% | 9.8% | 19.6% | 9.8% | 6.9% | 16.5% | 8.6% | 6.4% | 8.4% | |
| -50.2% | -15.4% | -100.6% | -68.0% | -37.2% | 12.8% | -62.4% | -60.9% | -265.4% | -11.9% | -86.3% | 12.0% | 15.7% | 37.9% | 4.2% | 28.2% | 34.6% | 38.1% | 45.4% | 52.3% | 57.5% | 39.5% | 57.9% | 55.3% | 64.3% | 67.4% | 63.3% | -1,002.2% | 28.1% | 25.8% | 6.6% | 20.0% | 19.0% | 26.5% | -88.2% | 44.4% | 55.7% | 1.0% | 61.2% | 65.2% | 53.3% | |
| 14.3% | 10.6% | 17.2% | 13.9% | 10.5% | 9.1% | 12.4% | 10.7% | 14.4% | 5.7% | 14.0% | 9.4% | 8.0% | 5.2% | 8.6% | 7.8% | 1.3% | 1.1% | 0.5% | -323.9% | 3.7% | 4.2% | 18.1% | 17.2% | 18.0% | 21.8% | 19.4% | 12.3% | 15.8% | 27.3% | 12.2% | 20.9% | 15.0% | 24.0% | 2.7% | 16.7% | 22.9% | 5.7% | 22.9% | 19.9% | 19.9% | |
| -50.2% | -15.4% | -100.6% | -68.0% | -37.2% | 12.8% | -62.4% | -60.9% | -265.4% | -11.9% | -86.3% | 12.0% | 15.7% | 37.9% | 4.2% | 28.2% | 33.3% | 37.0% | 44.9% | 376.1% | 53.8% | 35.3% | 39.8% | 38.1% | 46.3% | 45.6% | 43.9% | -989.2% | 13.5% | -0.9% | -5.6% | -0.9% | 4.0% | 2.5% | -90.9% | 27.7% | 32.8% | -4.8% | 38.3% | 45.4% | 33.4% | |
| -27.3% | -5.0% | -77.0% | -50.4% | -22.5% | 28.2% | -41.4% | -9.1% | -247.1% | -3.6% | -18.1% | 22.1% | 25.9% | 44.2% | 13.6% | 37.1% | 47.0% | 45.9% | 51.9% | 62.7% | 63.1% | 46.6% | 60.7% | 58.0% | 66.1% | 69.2% | 65.0% | 52.4% | 37.2% | 34.5% | 16.0% | 28.4% | 29.8% | 36.9% | -24.5% | 54.7% | 63.0% | 18.4% | 70.2% | 71.6% | 62.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.